Dr. Scott has served as the Chief Executive Officer of PharmaCann since its founding in 2015, where he utilizes his unique background in pharmaceutical research, intellectual property law, and entrepreneurship. Under his vision and leadership, PharmaCann has raised over $185M in capital and grown to over 275 full-time employees leading the institutionalization and acceptance of medical cannabis as a part of healthcare. PharmaCann currently operates three manufacturing sites and ten retail outlets in Illinois, New York, Massachusetts, and Maryland, and is currently operationalizing additional manufacturing and dispensary sites in Massachusetts, Pennsylvania, Ohio, Michigan and Virginia.

In December 2018, PharmaCann entered into an agreement to be acquired by MedMen in a deal valued at $682 million. Upon closing, the resulting pro-forma company is anticipated to have a portfolio of cannabis licenses across the U.S. that will permit the combined company to operate over 76 retail stores and 16 cultivation and production facilities. The combined company will operate in 12 states, which comprise a total estimated addressable market, as of 2030, of approximately $40 billion according to Cowen Group.

Prior to founding PharmaCann, Dr. Scott was an equity shareholder at Polsinelli PC, an American Lawyer Top-100 law firm and recognized leader in healthcare law. At Polsinelli, he was co-chair of the firm’s Emerging Enterprises practice group, focusing on businesses in the pharmaceutical, biotechnology, medical device, diagnostics, and information technology industries. As a registered patent attorney, Dr. Scott’s practice focused on a wide variety of patent licensing matters and intellectual property issues.

Dr. Scott is on the Board of Advisors for the University of Chicago Innovation Fund, which invests in proof-of-concept and early business development work for viable new start-ups. He has also served as a mentor to companies based on technologies developed at the University of Chicago, Northwestern University and the University of Illinois. His mentorship has focused on the strategy, formation, initial capital raising and initial operational stages of technology businesses.

Dr. Scott obtained his law degree from Northwestern University with a focus on business law and is currently licensed in Illinois and California. Dr. Scott obtained his Ph.D. in molecular biophysics from the University of Texas Southwestern Medical Center and his B.S. in biochemistry from Texas Tech University.